Literature DB >> 12113810

Synthesis and anti-influenza virus activity of 7-O-alkylated derivatives related to zanamivir.

Takeshi Honda1, Takeshi Masuda, Shuku Yoshida, Masami Arai, Satoru Kaneko, Makoto Yamashita.   

Abstract

A series of 7-alkyl ether derivatives related to zanamivir were synthesized using direct alkylation of the C-7 alcohol of sialic acid. Alkyl ether moiety of less than 12 carbons in length showed low nanomolar inhibitory activity against influenza A virus sialidase. Furthermore, their moiety improved influenza A virus plaque reduction activity compared to zanamivir. However, removal of the 8,9-diol of the 7-O-alkyl derivatives resulted in loss of antiviral potency. This result suggests that 8,9-diol must play an important role in binding with both influenza A and B virus sialidases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12113810     DOI: 10.1016/s0960-894x(02)00329-3

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  10 in total

1.  Consensus QSAR model for identifying novel H5N1 inhibitors.

Authors:  Nitin Sharma; Chun Wei Yap
Journal:  Mol Divers       Date:  2012-07-21       Impact factor: 2.943

2.  CS-8958, a prodrug of the new neuraminidase inhibitor R-125489, shows long-acting anti-influenza virus activity.

Authors:  Makoto Yamashita; Takanori Tomozawa; Masayo Kakuta; Akane Tokumitsu; Hatsumi Nasu; Shuku Kubo
Journal:  Antimicrob Agents Chemother       Date:  2008-10-27       Impact factor: 5.191

3.  Efficacy of the new neuraminidase inhibitor CS-8958 against H5N1 influenza viruses.

Authors:  Maki Kiso; Shuku Kubo; Makoto Ozawa; Quynh Mai Le; Chairul A Nidom; Makoto Yamashita; Yoshihiro Kawaoka
Journal:  PLoS Pathog       Date:  2010-02-26       Impact factor: 6.823

4.  A chemically programmed antibody is a long-lasting and potent inhibitor of influenza neuraminidase.

Authors:  Masahiko Hayakawa; Narihiro Toda; Nancy Carrillo; Natalie J Thornburg; James E Crowe; Carlos F Barbas
Journal:  Chembiochem       Date:  2012-09-10       Impact factor: 3.164

5.  CS-8958, a prodrug of the novel neuraminidase inhibitor R-125489, demonstrates a favorable long-retention profile in the mouse respiratory tract.

Authors:  Kumiko Koyama; Makoto Takahashi; Masataka Oitate; Naoko Nakai; Hideo Takakusa; Shin-ichi Miura; Osamu Okazaki
Journal:  Antimicrob Agents Chemother       Date:  2009-08-17       Impact factor: 5.191

6.  Synthesis and Biological Evaluation of Non-Hydrolizable 1,2,3-Triazole Linked Sialic Acid Derivatives as Neuraminidase Inhibitors.

Authors:  Michel Weïwer; Chi-Chang Chen; Melissa M Kemp; Robert J Linhardt
Journal:  European J Org Chem       Date:  2009-06

7.  Structural and functional analysis of laninamivir and its octanoate prodrug reveals group specific mechanisms for influenza NA inhibition.

Authors:  Christopher J Vavricka; Qing Li; Yan Wu; Jianxun Qi; Mingyang Wang; Yue Liu; Feng Gao; Jun Liu; Enguang Feng; Jianhua He; Jinfang Wang; Hong Liu; Hualiang Jiang; George F Gao
Journal:  PLoS Pathog       Date:  2011-10-20       Impact factor: 6.823

Review 8.  Antiviral agents active against influenza A viruses.

Authors:  Erik De Clercq
Journal:  Nat Rev Drug Discov       Date:  2006-12       Impact factor: 84.694

9.  Preventing Influenza A Virus Infection by Mixed Inhibition of Neuraminidase and Hemagglutinin by Divalent Inhibitors.

Authors:  Xuan Wei; Wenjuan Du; Margherita Duca; Guangyun Yu; Erik de Vries; Cornelis A M de Haan; Roland J Pieters
Journal:  J Med Chem       Date:  2022-05-12       Impact factor: 8.039

Review 10.  Current and future antiviral therapy of severe seasonal and avian influenza.

Authors:  John Beigel; Mike Bray
Journal:  Antiviral Res       Date:  2008-02-04       Impact factor: 5.970

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.